Insights

Conference Review: SCOPE 2018

Highlighting the recurring themes of Data, Analytics, Expertise, and Patient-centricity, 1,800 SCOPE attendees, among them many TayganPoint customers, recently congregated in Orlando, Florida not only to discuss new and innovative ways to move clinical research forward but also to donate 1,800 pentavalent vaccines through Greater Gift — one for every...

Read More

Opportunity Targeting: Fostering Increased Participation in Clinical Research

Site feasibility and selection are complex decision-making processes, with geographic availability of sites represents only one of the factors used. While states with large populations naturally have larger numbers of active Principal Investigators, certain states with large numbers of physicians have a relatively low percentage of physicians actively involved in...

Read More

CASE STUDY: ENSURING REGULATORY COMPLIANCE | ICH E6 (R2) Addendum | Optimizing Quality Risk Management

INDUSTRY CHALLENGE AND OPPORTUNITY: The recently revised ICH E6 (R2) Addendum provides both a challenge and opportunity for GCP organizations to modernize their QRM approaches.  By building quality in – starting with critical data & processes during  protocol development, using centralized and study risk-based monitoring, strengthening risk mitigation – organizations...

Read More

Social Responsibility: Life Science Leadership’s Next Secret Weapon

Entering Merck soon after Ken Frazier stepped down from President Trump’s Manufacturing Council, I was struck with newfound feelings of trust, connection and pride. Walking the halls, I found hundreds of people, from all backgrounds, ethnicities, ages enroute to contribute to Merck, it’s vision, and its mission. With recent events...

Read More

The Do’s and Don’ts of Business Transformation

On Oct. 12 Healthcare Businesswomen’s Association hosted a panel exploring the successes and failures of business transformation in life sciences. The panelists, who have all thankfully lived to tell the tale, shared their transformation do’s and don’ts based on pitfalls and successes of their endeavors. Transformation truly touches every level of...

Read More

Managing a Portfolio of Drug Development Projects: How to Find More Certainty in an Uncertain World

The drug development business is fraught with uncertainty.  Unpredictability in discovering and testing new molecular compounds or biologics – ranging from the scientific, operational, financial, regulatory, and organizational – are inherent parts of the process. This article is not about forever-eliminating uncertainty in the drug development process; that will never...

Read More

The Role of Technology and Innovation in Healthcare: Driving Business Success

Vitalized by technology-driven advances, yet constrained by complexity, healthcare and the ecosystem of the healthcare industry – pharma, biotech, providers, payers, government – is also changing at an accelerated rate. Regulatory and reporting requirements, patient-centricity expectations, and socio-demographic factors are bringing supply chain, R&D, and sales and marketing challenges to...

Read More

Archives